title: Neuroprotection by nitrous oxide and xenon and its relation to minimum alveolar concentration.
authors.forename: Jacques H
authors.initials: JH
authors.lastname: Abraini
authors.forename: Hélène N
authors.initials: HN
authors.lastname: David
authors.forename: Olivier
authors.initials: O
authors.lastname: Nicole
authors.forename: Eric T
authors.initials: ET
authors.lastname: MacKenzie
authors.forename: Alain
authors.initials: A
authors.lastname: Buisson
authors.forename: Marc
authors.initials: M
authors.lastname: Lemaire
mesh_terms: D018685:Anesthetics, Inhalation / Q000493:pharmacokinetics / Q000494:pharmacology*; D000818:Animals; D020244:Infarction, Middle Cerebral Artery / Q000517:prevention & control; D051379:Mice; D018696:Neuroprotective Agents; D009609:Nitrous Oxide / Q000493:pharmacokinetics / Q000494:pharmacology*; D011650:Pulmonary Alveoli / Q000378:metabolism*; D016194:Receptors, N-Methyl-D-Aspartate / Q000187:drug effects; D020521:Stroke / Q000188:drug therapy; D014978:Xenon / Q000493:pharmacokinetics / Q000494:pharmacology*
chemical_list: D018685:Anesthetics, Inhalation; D018696:Neuroprotective Agents; D016194:Receptors, N-Methyl-D-Aspartate; D014978:Xenon; D009609:Nitrous Oxide